as for the lozenge... I'm not surprised. Ugh, those things are awful, lol, and taste like paste. And the side effects... user error, but still. couldn't help ingesting some of the nic/saliva mix and... let's just say i was an unhappy camper.
The review article of Hukkanen et al. 2005 and a cursory ISI search identifies Schneider et al 2001, Clin Pharmacokinet, as the relevant reference on the delivery characteristics of the Nicotine Inhaler. After a ‘single dose’, constituted by 80 deep inhalations over a 20-minute period, plasma nicotine have been determined as Cmax = 8.1 +/- 2.5 ng/ml. If we reduce the nicotine dose - dividing by 8 - by instructing users to inhale ten times, what is the expected outcome?
To re-iterate: Do we expect (as an informed prediction, and for methods of Eissenberg 2010) to find plasma nicotine levels - after 10 inhalations from the Inhaler - that are statistically significant?
Tom09
Thanks, Tom E,
for responding to my question, what results to expect if a study like Eissenberg 2010 would be done on the pharmaceutical Nicotine Inhaler - a delivery device with known and published properties. Though Bullen’s preliminary data is interesting, by indicating where delivery from e-cigs & Inhaler might possibly hit, specifics about their dosing are presently not known to me. Thanks for pointing to the 2-mg lozenge test, will certainly have a read into it.
I’ll try to be a bit more specific and hope on your patience with this non-native speaker:
The review article of Hukkanen et al. 2005 and a cursory ISI search identifies Schneider et al 2001, Clin Pharmacokinet, as the relevant reference on the delivery characteristics of the Nicotine Inhaler. After a ‘single dose’, constituted by 80 deep inhalations over a 20-minute period, plasma nicotine have been determined as Cmax = 8.1 +/- 2.5 ng/ml. If we reduce the nicotine dose - dividing by 8 - by instructing users to inhale ten times, what is the expected outcome?
To re-iterate: Do we expect (as an informed prediction, and for methods of Eissenberg 2010) to find plasma nicotine levels - after 10 inhalations from the Inhaler - that are statistically significant?
Tom09
I love where this has gone:
Smoking is a two-pronged activity -- habit and addiction. With e-smoking, the habit is nicely addressed. Consider: In my case, I smoked 30 cigarettes a day for 50 years. I did hand-to-mouth with a cigarette 4.5-million times. That makes a pretty strong habit. I've replaced my habit with one involving electronic cigarettes.
And some on this forum have left smoking behind just by breaking their "bad habit." That's wonderful. But even if only habit is addressed, e-cigs are the most effective "quit" solution yet available for smokers, far superior to lozenges and patches and gums and nasal sprays. They most closely replicate smoking. They do what Big Pharma's expensive NRT products can't. I feel the inhale; I see the exhalation.
But, with only e-cigs, I could not escape the addiction. Cravings remained. Overwhelming at times. So I threw every nicotine alternative into the mix and now use snus, dissolvables and nasal snuff on a daily basis, fully concurrent with vaping non-stop.
In this way, both the habit and the addiction can be replaced with what I consider a healthier practice.
They call it .. harm reduction. And I'm a believer.
Tom09 is hitting on something here that's been bothering me throughout this whole discussion.
The use of an ecig simply cannot be compared to the use of a cigarette on a puff per puff basis. 10 puffs on an ecig is in no way the equivalent of 10 puffs of a cigarette. We all know that Dr. Laugesen estimates the ecig puff renders about 1/10th the nicotine as a cigarette puff. If he is anywhere near correct, the study subjects would have had to take up to 100 puffs on the ecig to fairly measure nicotine intake as compared to the 10 puffs on a cigarette they were taking.
Further, from several of Dr. E's posts, I wonder if he realizes the amount of nicotine an ecig cartridge is even supposed to contain. He's mentioned a cartridge containing "16 mg" - but I believe his study used only super-mini type ecigs (certainly the Npro is a super-mini), the cartridges for which can only hold around .3 of a ml. Thus given 16 mg liquid, which is 16 mg per ml, the cartridges he used, when full, probably contained only around 4.8 mg of nicotine. The nicotine content of prefilled cartridges is measured and stated the same way as is the nicotine content of eliquid - in mg per ml. So a big 801 cartridge filled with 16 mg eliquid will contain close to 16 mg of nicotine, as it holds close to a full ml, but those super-minis certainly do not!
And, it's generally accepted here that around 20 to 25 drops of eliquid approximate 1 ml. Wouldn't one drop on your atomizer get you at least 10 puffs, if not more? So if we use 25 drops as the measure, and assume 10 puffs is going to actually consume 1 whole drop of eliquid (but which it probably won't), then the most nicotine you could likely expect to get from those 10 puffs off an ecig, with 16 mg eliquid, is .64 of a mg. And that's only if 100% of the nicotine is vaporized (and does not begin to take into account the likelihood that not all of it will be absorbed by the user).
Voltaire:
I really appreciate the idea and, even more, the implied confidence in me that lies behind it.
I fear that such a project would open me up to the same types of criticism that are made at the beginning of this thread. Instead of "bought and paid for by the tobacco industry" it would be "bought and paid for by the vapers". Even if the study were not published, the project would necessarily involve a contract of some sort between a vaper (or group of vapers) and VCU, and money woudl change hands. At that point, there would be the appearance of a conflict of interest associated with all of my subsequent e-cigarette work.
I hope you can appreciate this position.

Voltaire:
I really appreciate the idea and, even more, the implied confidence in me that lies behind it.
I fear that such a project would open me up to the same types of criticism that are made at the beginning of this thread. Instead of "bought and paid for by the tobacco industry" it would be "bought and paid for by the vapers". Even if the study were not published, the project would necessarily involve a contract of some sort between a vaper (or group of vapers) and VCU, and money woudl change hands. At that point, there would be the appearance of a conflict of interest associated with all of my subsequent e-cigarette work.
I hope you can appreciate this position.
KK: Thanks for the offer. I'd love a beer in Hawai'i!
There is reason to believe that is true to some degree.
ScienceDirect - Pharmacology Biochemistry and Behavior : Cue dependency of nicotine self-administration and smoking
In this way, both the habit and the addiction can be replaced with what I consider a healthier practice.
They call it .. harm reduction. And I'm a believer.
I do realize this, as I'm sure others do - I didn't mean to suggest otherwise. Though, it's my belief that the majority of people who are able to fully transition from cigs to ecigs use much more efficient devices and probably slightly stronger eliquids than the ones used in your study.And Voltaire (and others) I hope you'll recall that I never said under no circumstances would any e-cig at any strength liquid deliver any dose of nicotine. My published study does not address that statement at all.
The two most popular devices recommended on this board are the 510 manufactured by Joye, and the KR808 manufactured by Kanger. The 510 is a 3-piece (battery, atomizer, cartridge) and the KR808 is a 2-piece (battery and "cartomizer" - which is the cartridge and atomizer integrated into 1-piece).So can you folks agree on one unmodified device and one marketed cartridge that you are as certain as you can be (without a blood test) delivers nicotine? If you can, I'll get it and see where we can go from there. I can tell you that there is no way an IRB is going to allow device modifications and/or this "dripping" procedure, so it would have to be off-the-shelf stuff